Mayumi Imahashi
Overview
Explore the profile of Mayumi Imahashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yokomaku Y, Noda T, Imahashi M, Nishioka Y, Myojin T, Iwamoto A, et al.
PLoS One
. 2025 Jan;
20(1):e0317655.
PMID: 39869625
No updated data on people living with HIV (PLHIV) in Japan have been available since 2015, leaving a critical gap in understanding the current status of care and treatment. Therefore,...
2.
Iwatani Y, Matsuoka K, Ode H, Kubota M, Nakata Y, Setoyama Y, et al.
mBio
. 2025 Jan;
16(3):e0333224.
PMID: 39835817
The human cellular cytidine deaminases APOBEC3s (A3s) inhibit virion infectivity factor (Vif)-deficient HIV-1 replication. However, virus-encoded Vifs abolish this defense system by specifically recruiting A3s to an E3 ubiquitin ligase...
3.
Ode H, Matsuda M, Shigemi U, Mori M, Yamamura Y, Nakata Y, et al.
Sci Rep
. 2024 May;
14(1):12099.
PMID: 38802662
HIV-1 drug resistance genotypic tests have primarily been performed by Sanger sequencing of gene segments encoding different drug target proteins. Since the number of targets has increased with the addition...
4.
Uno S, Gatanaga H, Hayashida T, Imahashi M, Minami R, Koga M, et al.
J Antimicrob Chemother
. 2023 Oct;
78(12):2859-2868.
PMID: 37856677
Background: Integrase strand transfer inhibitors (INSTIs) are recommended as first-line ART for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated mutation E157Q, a highly prevalent (2%-5%) polymorphism of...
5.
Mizuki K, Ishimaru T, Imahashi M, Ikushima Y, Takahashi H, Masuda M, et al.
Environ Health Prev Med
. 2023 Sep;
28:52.
PMID: 37743522
Background: To examine workplace factors associated with willingness to undergo human immunodeficiency virus (HIV) testing during workplace health checkups. Methods: This cross-sectional study used an Internet-based self-administered questionnaire to obtain...
6.
Masuda M, Ikushima Y, Ishimaru T, Imahashi M, Takahashi H, Yokomaku Y
Sangyo Eiseigaku Zasshi
. 2023 Jul;
65(6):366-369.
PMID: 37407485
No abstract available.
7.
Otani M, Shiino T, Hachiya A, Gatanaga H, Watanabe D, Minami R, et al.
J Int AIDS Soc
. 2023 May;
26(5):e26086.
PMID: 37221951
Introduction: Late diagnosis of the human immunodeficiency virus (HIV) is a major concern epidemiologically, socially and for national healthcare systems. Although the association of certain demographics with late HIV diagnosis...
8.
Nakata Y, Ode H, Kubota M, Kasahara T, Matsuoka K, Sugimoto A, et al.
Nucleic Acids Res
. 2023 Jan;
51(2):783-795.
PMID: 36610792
The number of genetic variations in the SARS-CoV-2 genome has been increasing primarily due to continuous viral mutations. Here, we report that the human APOBEC3A (A3A) cytidine deaminase plays a...
9.
Kawatsu L, Kaneko N, Imahashi M, Kamada K, Uchimura K
AIDS Res Ther
. 2022 Dec;
19(1):60.
PMID: 36463211
Background: Tuberculosis (TB) continues to be the leading cause of death for people living with HIV/AIDS (PLHIV), and HIV is the strongest known risk factor for progression to active TB...
10.
Mori M, Ode H, Kubota M, Nakata Y, Kasahara T, Shigemi U, et al.
Microbiol Spectr
. 2022 Jul;
10(4):e0150722.
PMID: 35894615
High genetic diversity, including the emergence of recombinant forms (RFs), is one of the most prominent features of human immunodeficiency virus type 1 (HIV-1). Conventional detection of HIV-1 RFs requires...